Identification of viral antigens recognized by ocular infiltrating T cells from patients with varicella zoster virus-induced uveitis

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 8, 2007, Pages 3689-3697

  Milikan, Johannes C M ^a,b   Kinchington, Paul R ^c   Baarsma, G Seerp ^b   Kuijpers, Robert W A M ^a   Osterhaus, Albert D M E ^a   Verjans, Georges M G M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ROTTERDAM EYE HOSPITAL   (Netherlands)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; VIRUS ANTIGEN; CYTOKINE; HLA ANTIGEN CLASS 2;

ADULT; AGED; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; AQUEOUS HUMOR; ARTICLE; B LYMPHOCYTE; CELL ACTIVITY; CELL CLONE; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTIC INFILTRATION; MALE; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; UVEITIS; VARICELLA ZOSTER VIRUS; VIRUS IDENTIFICATION; ADOLESCENT; AMINO ACID SEQUENCE; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; GENETICS; HERPES ZOSTER; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; SECRETION; TH1 CELL; VIROLOGY;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ANTIGENS, VIRAL; AQUEOUS HUMOR; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; CYTOKINES; EPITOPES; EPITOPES, T-LYMPHOCYTE; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOLOGIC MEMORY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; UVEITIS;

EID: 34648837151     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.07-0020     Document Type: Article

References (47)

1. Arvin AM. Varicella-zoster virus. In: Knipe DM, Howley PM, Griffin DE et al., eds. Fields Virology. Vol 2, 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001:2731-2760.
2. Kinchington PR. Latency of varicella zoster virus; a persistently perplexing state. Front Biosci. 1999;15:200-211.
3. Liesegang TJ. Varicella-zoster virus eye disease. Cornea. 1999;18:511-531.
4. Zerboni L, Ku CC, Jones CD, Zehnder JL, Arvin AM. Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc Natl Acad Sci USA. 2005;102:6490-6495.
5. Cohen JI, Straus SE. Varicella-zoster virus and its replication. In: Knipe DM, Howley PM, Griffin DE, et al., eds. Fields Virology. Vol 2, 4th ed., Philadelphia: Lippincott Williams & Wilkins; 2001: 2707-2730.
6. Grinfeld E, Kennedy PG. Translation of varicella-zoster virus genes during human ganglionic latency. Virus Genes. 2004;29:317-319.
7. Arvin AM, Sharp M, Smith S, et al. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype. J Immunol. 1991;146:257-264.
8. Levin MJ, Smith JG, Kaufhold RM, et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis. 2003;188:1336-1344.
9. Ritterband DC, Friedberg DN. Virus infections of the eye. Rev Med Virol. 1998;8:187-201.
10. Deschenes J, Freeman WR, Char DH, Garovoy MR. Lymphocyte subpopulations in uveitis. Arch Ophthalmol. 1986;104:233-236.
11. Wang XC, Norose K, Yano A, Ohta K, Segawa K. Two-color flow cytometric analysis of activated T lymphocytes in aqueous humor of patients with endogenous vs. exogenous uveitis. Curr Eye Res. 1995;14:425-433.
12. Atherton SS, Altaian NH, Streilein JW. Histopathologic study of herpes virus-induced retinitis in athymic BALB/c mice: evidence for an immunopathogenic process. Curr Eye Res. 1989;8:1179-1192.
13. Atherton SS. Acute retinal necrosis: insights into pathogenesis from the mouse model. Herpes. 2001;8:69-73.
14. Milikan JCM, Kuijpers RWAM, Baarsma GS, Osterhaus ADME, Verjans GMGM. Characterization of the Varicella Zoster Virus (VZV)-specific intraocular T-cell response in patients with VZV-induced uveitis. Exp Eye Res. 2006;83:69-75.
15. Verjans GMGM, Feron EJ, Dings ME, et al. T-cells specific for the triggering virus infiltrate the eye in patients with herpes simplex virus-mediated acute retinal necrosis. J Infect Dis. 1998;178:27-34.
16. Verjans GMGM, Dings ME, McLauchlan J, et al. Intraocular T-cells of patients with herpes simplex virus (HSV)-induced acute retinal necrosis recognize HSV tegument proteins VP11/12 and VP13/14. J Infect Dis. 2000;182:923-927.
17. Koelle DM, Reymond SN, Chen H, et al. Tegument-specific, virus-reactive CD4 T-cells localize to the cornea in herpes simplex virus interstitial keratitis in humans. J Virol. 2000;74:10930-10938.
18. Koelle DM, Schomogyi M, McClurkan C, Reymond SN, Chen HB. CD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteins. J Virol. 2000;74:11422-11425.
19. Arvin AM, Scharp M, Moir M, et al. Memory cytotoxic T-cell responses to viral tegument and regulatory proteins encoded by open reading frames 4, 10, 29, and 62 of varicella-zoster virus. Viral Immunol. 2002;15:507-516.
20. Trannoy E, Berger R, Hollander G, et al. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial. Vaccine. 2000;18:1700-1706.
21. Jones L, Black AP, Malavige GN, Ogg GS. Persistent high frequencies of varicella-zoster virus ORF4 protein-specific CD4+ T-cells after primary infection. J Virol. 2006;80:9772-9778.
22. De Groot-Mijnes JD, Rotova A, Van Loon AM, et al. Polymerase chain reaction and Goldmann-Witmer coefficient analysis are complimentary for the diagnosis of infectious uveitis. Am J Ophthalmol. 2006;141:313-318.
23. Sadzot-Delvaux C, Kinchington PR, Debrus S, Rentier B, Arvin AM. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes. J Immunol. 1997;159:2802-2806.
24. Flower DR. Towards in silico prediction of immunogenic epitopes. Trends Immunol. 2003;24:667-674.
25. Reche PA, Glutting JP, Reinherz EL. Prediction of MHC class I binding peptides using profile motifs. Hum Immunol. 2002;63:701-709.
26. Singh H, Raghava GPS. ProPred: Prediction of HLA-DR binding sites. Bioinformatics. 2001;17:1236-1237.
27. Rammensee HG, Bachmann J, Emmerich NN, Bachor OA, Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics. 1999;50:213-219.
28. de Waal L, Yuksel S, Brandenburg AH, et al. Identification of a common HLA-DP4-restricted T-cell epitope in the conserved region of the respiratory syncytial virus G protein. J Virol. 2004;78:1775-1781.
29. Turner SJ, Doherty PC, McCluskey J, Rossjohn J. Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol. 2006;12:883-894.
30. Lee-MacAry AE, Ross EL, Davies D, et al. Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide. J Immunol Methods. 2001;252:83-92.
31. van Baalen CA, Kwa D, Verschuren EJ, et al. Fluorescent antigen-transfected target-cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity. J Infect Dis. 2005;192:1183-1190.
32. Kelso A. Th1 and Th2 subsets: paradigms lost? Immunol Today. 1995;16:374-379.
33. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T-cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745-763.
34. Casazza JP, Betts MR, Price DA, et al. Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J Exp Med. 2006;203:2865-2877.
35. Picker LJ, Terstappen LW, Rott LS, Streeter PR, Stein H, Butcher EC. Differential expression of homing-associated adhesion molecules by T-cell subsets in man. J Immunol. 1990;145:3247-3255.
36. Asanuma H, Sharp M, Maecker HT, Maino VC, Arvin AM. Frequencies of memory T-cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression. J Infect Dis. 2000;181:859-866.
37. Huang Z, Vafai A, Lee J, Mahalingam R, Hayward AR. Specific lysis of targets expressing varicella-zoster virus gpl or gpIV by CD4+ human T-cell clones. J Virol. 1992;66:2664-2669.
38. Vossen MT, Gent MR, Weel JF, de Jong MD, van Lier RA, Kuijpers TW. Development of virus-specific CD4+ T-cells on reexposure to varicella-zoster virus. J Infect Dis. 2004;190:72-82.
39. Feron EJ, Klaren VN, Wierenga EA, Verjans GMGM, Kijlstra A. Characterization of Toxoplasma gondii-specific T-cells recovered from vitreous fluid of patients with ocular toxoplasmosis. Invest Ophthalmol Vis Sci. 2001;42:3228-3232.
40. Bergen RE, Sharp M, Sanchez A, Judd AK, Arvin AM. Human T-cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus. Viral Immunol. 1991;4:151-166.
41. Frey CR, Sharp MA, Min AS, Schmid DS, Loparev V, Arvin AM. Identification of CD8+ T-cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T-cell response to IE62, by use of IE62 peptides after varicella vaccination. J Infect Dis. 2003;188:40-52.
42. Hayward AR. T-cell responses to predicted amphipathic peptides of varicella-zoster virus glycoproteins II and IV. J Virol. 1990;64:651-655.
43. Jenkins DJ, Yasukawa LL, Bergen R, Benike C, Engleman EG, Arvin AM. Comparison of primary sensitization of naive human T-cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination. J Immunol. 1999;162:560-567.
44. Hosken N, McGowan P, Meier A, et al. Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes. J Virol. 2006;80:5509-5515.
45. + herpes simplex virus-specific T-cells in patients with herpetic stromal keratitis. J Infect Dis. 2003;187:550-558.
46. + cell clonotypes in infected tissues and blood. J Infect Dis. 2005;191:2012-2021.
47. Gray WL. Simian varicella: a model for human varicella-zoster virus infections. Rev Med Virol. 2004;14:363-381.